Adobe reportedly won’t offer remedies to address EU concerns over Figma deal

Adobe reportedly won’t offer remedies to address EU concerns over Figma deal

tumsasedgars/iStock via Getty Images

Adobe (NASDAQ:ADBE) is increasingly likely to face an in-depth review from the European Union’s antitrust regulator concerning its proposed $20B Figma acquisition.

San Jose, California-based Adobe (ADBE) will not offer remedies to address the concerns of the agency, Bloomberg

Source link